We are live on !
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
Turnover
60.61%
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
+$8.29M
(+14%)
Cap. Flow
+$2.99M
Cap. Flow % of AUM
Cap. Flow %
4.5%
Top 10 Holdings %
Top 10 Hldgs %
32.21%
Holding
297
New
108
Increased
49
Reduced
51
Closed
72
Avg Time Held
Equity + Options
0.5
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$3.53M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$2.94M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$2.18M |
| 4 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
+$1.54M |
| 5 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$1.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Mills
GIS
|
+$2.52M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$2.31M |
| 3 |
Amgen
AMGN
|
+$2.08M |
| 4 |
Abbott
ABT
|
+$1.72M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.45% |
| 2 | Miscellaneous | 41.8% |
| 3 | Consumer Discretionary | 7.1% |
| 4 | Consumer Staples | 6.25% |
| 5 | Communication Services | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
PUT
Coca-Cola
KO
$399B
| $4K | 0.01% |
5,800
-11,200
| -66% | -$509K |
2016 Q3
4 quarters
|
|
202
CALL
RTX Corp
RTX
$258B
| $4K | 0.01% |
+20,816
| New | +$1.54M |
2017 Q3
0 quarters
|
|
|
PRTK
203
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4K | 0.01% |
+7,800
| New | +$182K |
2017 Q3
0 quarters
|
|
|
CASC
204
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $4K | 0.01% |
+4,000
| New | +$15.3K |
2017 Q3
0 quarters
|
|
205
PUT
Hain Celestial
HAIN
$21.4M
| $3K | ﹤0.01% |
3,500
-17,500
| -83% | -$723K |
2017 Q1
2 quarters
|
|
206
CALL
Harley-Davidson
HOG
$2.82B
| $3K | ﹤0.01% |
10,000
+1,500
| +18% | +$73K |
2017 Q2
1 quarter
|
|
207
CALL
Mondelez International
MDLZ
$81.6B
| $3K | ﹤0.01% |
42,800
-3,700
| -8% | -$157K |
2016 Q2
5 quarters
|
|
|
208
PUT
Abbott
ABT
$178B
| $2K | ﹤0.01% |
35,000
| – | – |
2016 Q3
4 quarters
|
|
209
PUT
Alibaba
BABA
$271B
| $2K | ﹤0.01% |
10,000
| – | – |
2015 Q4
7 quarters
|
|
210
PUT
DELISTED
Esperion Therapeutics
ESPR
| $2K | ﹤0.01% |
7,800
-55,200
| -88% | -$2.66M |
2017 Q1
2 quarters
|
|
211
PUT
Children's Place
PLCE
$24.5M
| $2K | ﹤0.01% |
+11,600
| New | +$1.25M |
2017 Q3
0 quarters
|
|
|
OTIC
212
CALL
DELISTED
Otonomy, Inc.
OTIC
| $2K | ﹤0.01% |
67,300
+33,800
| +101% | +$456K |
2017 Q1
2 quarters
|
|
213
CALL
DELISTED
CA, Inc.
CA
| $2K | ﹤0.01% |
10,000
| – | – |
2017 Q2
1 quarter
|
|
214
PUT
Coca-Cola Europacific Partners
CCEP
$49.6B
| $1K | ﹤0.01% |
1,900
| – | – |
2016 Q2
5 quarters
|
|
215
CALL
Church & Dwight Co
CHD
$25B
| $1K | ﹤0.01% |
+16,500
| New | +$838K |
2017 Q3
0 quarters
|
|
216
CALL
DELISTED
Foot Locker
FL
| $1K | ﹤0.01% |
+7,500
| New | +$315K |
2017 Q3
0 quarters
|
|
|
217
PUT
DELISTED
Foot Locker
FL
| $1K | ﹤0.01% |
+5,000
| New | +$210K |
2017 Q3
0 quarters
|
|
218
PUT
Insmed
INSM
$20.8B
| $1K | ﹤0.01% |
145,500
+37,900
| +35% | +$722K |
2017 Q1
2 quarters
|
|
219
PUT
DELISTED
Big Lots, Inc.
BIG
| $1K | ﹤0.01% |
+5,000
| New | +$246K |
2017 Q3
0 quarters
|
|
|
RAD
220
CALL
DELISTED
Rite Aid Corporation
RAD
| $1K | ﹤0.01% |
1,525
| – | – |
2017 Q2
1 quarter
|
|
|
COL
221
PUT
DELISTED
Rockwell Collins
COL
| $1K | ﹤0.01% |
+961
| New | +$117K |
2017 Q3
0 quarters
|
|
|
GGP
222
CALL
DELISTED
GGP Inc.
GGP
| $1K | ﹤0.01% |
+10,000
| New | +$219K |
2017 Q3
0 quarters
|
|
|
ZGNX
223
PUT
DELISTED
Zogenix, Inc.
ZGNX
| $1K | ﹤0.01% |
+58,600
| New | +$795K |
2017 Q3
0 quarters
|
|
224
CALL
Agilent Technologies
A
$49B
| – | – |
-15,500
| Closed | -$1K | – |
|
|
225
Agilent Technologies
A
$49B
| – | – |
-3,236
| Closed | -$192K | – |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q3 2017 Portfolio in Review
As of Q3 2017, FT Options held 297 positions worth $66.4M, up 14% from $58.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
FT Options deployed $2.99M of net new capital in Q3 2017, opening 108 new positions and adding to 49 existing holdings. Its largest new stake was Incyte: 27,887 shares worth $3.26M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was General Mills, an estimated $2.52M trimmed.
- FT Options's largest Q3 2017 buy was Incyte: 27,887 shares worth $3.26M.
- FT Options added most to Sio Gene Therapies Inc. Common Stock in Q3 2017, an estimated $1.37M increase.
- FT Options's biggest Q3 2017 reduction was General Mills, cutting an estimated $2.52M.
- FT Options fully exited Portola Pharmaceuticals, Inc. in Q3 2017, selling an estimated $2.31M.
- FT Options's ten largest holdings make up 32% of its $66.4M portfolio in Q3 2017.
- FT Options opened 108 new positions and closed 72 in Q3 2017.
- FT Options's portfolio value rose 14% quarter-over-quarter to $66.4M.
Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.